These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
541 related articles for article (PubMed ID: 17324465)
1. Use of autologous platelet-rich plasma in the treatment of dormant corneal ulcers. Alio JL; Abad M; Artola A; Rodriguez-Prats JL; Pastor S; Ruiz-Colecha J Ophthalmology; 2007 Jul; 114(7):1286-1293.e1. PubMed ID: 17324465 [TBL] [Abstract][Full Text] [Related]
2. Autologous fibrin membrane combined with solid platelet-rich plasma in the management of perforated corneal ulcers: a pilot study. Alio JL; Rodriguez AE; Martinez LM; Rio AL JAMA Ophthalmol; 2013 Jun; 131(6):745-51. PubMed ID: 23559361 [TBL] [Abstract][Full Text] [Related]
3. Treatment with platelet-rich plasma of surgically related dormant corneal ulcers. Alio JL; Rodriguez AE; De Arriba P; Gisbert S; Abdelghany AA Eur J Ophthalmol; 2018 Sep; 28(5):515-520. PubMed ID: 29566537 [TBL] [Abstract][Full Text] [Related]
4. Amniotic membrane transplantation combined with antiviral and steroid therapy for herpes necrotizing stromal keratitis. Shi W; Chen M; Xie L Ophthalmology; 2007 Aug; 114(8):1476-81. PubMed ID: 17363059 [TBL] [Abstract][Full Text] [Related]
5. A comparison of the efficacy of autologous serum eye drops with amniotic membrane transplantation in neurotrophic keratitis. Turkoglu E; Celik E; Alagoz G Semin Ophthalmol; 2014 May; 29(3):119-26. PubMed ID: 23758337 [TBL] [Abstract][Full Text] [Related]
6. Amniotic membrane transplantation for persistent corneal ulcers and perforations in acute fungal keratitis. Chen HC; Tan HY; Hsiao CH; Huang SC; Lin KK; Ma DH Cornea; 2006 Jun; 25(5):564-72. PubMed ID: 16783145 [TBL] [Abstract][Full Text] [Related]
7. Bovine pericardium membrane (tutopatch) combined with solid platelet-rich plasma for the management of perforated corneal ulcers. Alio JL; Rodriguez AE; Martinez LM Cornea; 2013 May; 32(5):619-24. PubMed ID: 22929158 [TBL] [Abstract][Full Text] [Related]
8. [Multilayer amniotic membrane transplantation for corneal ulcers not treatable by conventional therapy - a prospective study of the status of cornea and graft during follow-up]. Ferreira De Souza R; Hofmann-Rummelt C; Kruse FE; Seitz B Klin Monbl Augenheilkd; 2001 Aug; 218(8):528-34. PubMed ID: 11573153 [TBL] [Abstract][Full Text] [Related]
9. [Autologous serum for otherwise therapy resistant corneal epithelial defects - Prospective report on the first 70 eyes]. Ferreira de Souza R; Kruse FE; Seitz B Klin Monbl Augenheilkd; 2001 Nov; 218(11):720-6. PubMed ID: 11731899 [TBL] [Abstract][Full Text] [Related]
10. Topical autologous platelet-rich plasma eyedrops for acute corneal chemical injury. Panda A; Jain M; Vanathi M; Velpandian T; Khokhar S; Dada T Cornea; 2012 Sep; 31(9):989-93. PubMed ID: 22759830 [TBL] [Abstract][Full Text] [Related]
11. Symptomatic dry eye treatment with autologous platelet-rich plasma. Alio JL; Colecha JR; Pastor S; Rodriguez A; Artola A Ophthalmic Res; 2007; 39(3):124-9. PubMed ID: 17374962 [TBL] [Abstract][Full Text] [Related]
12. Application of umbilical cord serum eyedrops for the treatment of neurotrophic keratitis. Yoon KC; You IC; Im SK; Jeong TS; Park YG; Choi J Ophthalmology; 2007 Sep; 114(9):1637-42. PubMed ID: 17382396 [TBL] [Abstract][Full Text] [Related]
13. [Application of amniotic membrane transplantation in severe corneal diseases]. Rakowska E; Zagórski Z; Kardaszewska A; Durakiewicz D Klin Oczna; 1999; 101(6):417-21. PubMed ID: 10786047 [TBL] [Abstract][Full Text] [Related]
14. Autologous serum eyedrops in the treatment of aniridic keratopathy. López-García JS; Rivas L; García-Lozano I; Murube J Ophthalmology; 2008 Feb; 115(2):262-7. PubMed ID: 17675158 [TBL] [Abstract][Full Text] [Related]
15. [Multilayer amniotic membrane transplantation for treatment of necrotizing herpes simplex stromal keratitis]. Shi WY; Chen M; Wang FH; Zhao J; Ma L; Xie LX Zhonghua Yan Ke Za Zhi; 2005 Dec; 41(12):1107-11. PubMed ID: 16409765 [TBL] [Abstract][Full Text] [Related]
16. Plasma rich in growth factors as a therapeutic agent for persistent corneal epithelial defects. López-Plandolit S; Morales MC; Freire V; Etxebarría J; Durán JA Cornea; 2010 Aug; 29(8):843-8. PubMed ID: 20508516 [TBL] [Abstract][Full Text] [Related]
17. [Treatment of corneal ulcerations with use of the amniotic membrane]. Gierek-Łapińska A; Mrukwa-Kominek E; Rokita-Wala I; Gierek-Ciaciura S Klin Oczna; 2001; 103(2-3):95-100. PubMed ID: 11873419 [TBL] [Abstract][Full Text] [Related]
18. Outcome of treatment of mooren ulcer with topical cyclosporine a 2%. Tandon R; Chawla B; Verma K; Sharma N; Titiyal JS Cornea; 2008 Sep; 27(8):859-61. PubMed ID: 18724142 [TBL] [Abstract][Full Text] [Related]
19. Chronic wounds treated with a physiologically relevant concentration of platelet-rich plasma gel: a prospective case series. Frykberg RG; Driver VR; Carman D; Lucero B; Borris-Hale C; Fylling CP; Rappl LM; Clausen PA Ostomy Wound Manage; 2010 Jun; 56(6):36-44. PubMed ID: 20567053 [TBL] [Abstract][Full Text] [Related]
20. Topical treatment with a new matrix therapy agent (RGTA) for the treatment of corneal neurotrophic ulcers. Aifa A; Gueudry J; Portmann A; Delcampe A; Muraine M Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8181-5. PubMed ID: 23150626 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]